1760 A
1.00 10.05 0.67 9.38 1,760 17,688.00 1171.00 16517.00
2
...7...10...10...11...12...13...14...14...15...17...17...18...18...19...23...25...26...27...29...30...31...33...33...33...47...48...49...51...52...57...60...60...67...69...73...86...88...89...92
...93...96...100...101...103...103...108...109...109...110.113...113...114...115...115...118...118...119 119...119...120...120...121...122...123...124...125...126...126...127...127 128...131...131...132...137...141...147...148...152...152
...154...154...155...160...162...163...171...172...172...174...175...175...176...176...177...177...177...178...179...195...195...195...196...197...198...198...198...199...199...205...206...212
ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD. 5010 2001 10 25 312500 05756176531 05756096898 www.jingxinpharm.com jingxin@mail.sxptt.zj.cn 2001 9 29 [2001]80 2001 10 25
2005 12 31 2003 12 9 [2004]001 2003/12/31 2002/12/31 2001/12/31 142,108,973.75 114,132,931.96 116,260,819.71 3,600,000.00 100,000.00 0 91,341,161.33 48,529,075.22 28,327,662.64 258,804,836.59 182,372,417.11 152,500,551.07 139,276,259.21 98,283,766.84 110,795,669.59 31,087,557.50 21,068,298.63 1,032,200.00 170,363,816.71 119,352,065.47 111,827,869.59 88,441,019.88 63,020,351.64 40,672,681.48
2003 2002 2001 301,505,638.48 269,954,197.42 227,052,570.30 79,546,040.55 59,805,423.08 40,686,218.84 32,010,338.55 25,475,467.96 13,984,613.45 32,618,748.05 28,002,760.54 15,407,521.52 25,404,521.24 22,282,397.16 9,972,477.64 2003 2002 46,175,878.60 32,993,604.83-74,690,588.91-45,492,780.93 25,602,879.86 23,265,995.03-2,950,491.71 10,761,813.20 2003/12/31 2002/12/31 2001/12/31 % 65.83 65.44 73.33 / 1.77 1.26 1.36 / 0.507 0.445 0.332 / 0.922 0.659 0.030 % 28.725 35.357 24.519 A 1.00 / 10.05 / 1,760 17,688.00
16,517.00 0.507 / 19.82 1.77 3.75 1,760 A 2003 12 31 2003 12 31 2003 12 31 17688 1171 16517 1 500 4,490.00 0 4,490.00 2 400 4,918.00 0 4,918.00 3 FDA 2,856.00 0 2,856.00 4 12 () 4,192.00 0 4,192.00 16,456.00 0 16,456.00 4
16,517.00
501402112009696
2
ERP 6 2003 12 31 25,880.48 8,844.10 200120022003 22,705.2626,995.4230,150.56 2002 87
10 1 WTO
2005 12 31
1,090,000.00 1,004,711.47 815,276.00 4,010,219.00 5,915,495.00 850,000.00 1,398,628.23 1,134,921.00 3,127,235.00 5,112,156.00 470,000.00 1,792,100.34 1,454,205.00 1,729,177.00 3,653,382.00 780,000.00 2,869,698.00 3,649,698.00 60,000.00 504,020.82 408,990.00 220,746.00 689,736.00 100,000.00 223,368.03 181,253.00 367,910.00 649,163.00 100,000.00 223,368.03 181,253.00 367,910.00 649,163.00 630,000.00 511,216.00 511,216.00 60,000.00 214,020.80 173,668.00 220,746.00 454,414.00
500,000.00 405,727.00 405,727.00 60,000.00 154,020.82 124,981.00 220,746.00 405,727.00 60,000.00 154,020.82 124,981.00 220,746.00 405,727.00 270,000.00 219,092.00 219,092.00 3,630,000.00 7,068,259.36 5,735,563.00 13,355,133.00 22,720,696.00 1 5,915,495.00 26.035 2 5,112,156.00 22.500 3 3,653,382.00 16.080 4 3,649,698.00 16.063 5 689,736.00 3.036 6 649,163.00 2.857 7 649,163.00 2.857 8 511,216.00 2.250 9 454,414.00 2.000
67.5 53.5715 2.25%1.786%
2
56.49% 22.500% 54.643%
1998 12 10
GMP 2000 1 1999 12 31 22.82 45.13 22.31 3
10 90% 10% 82.933% 17.067% 12.89% 5% 85% 90% 90% 10% 8 16.063% 37.758% 16.08% 26.063% 2.25% 1.786% 11.11% 90%
2000 1 1 GMP GCP GSP GAP 2004 6 30 GMP
20 17 5 1213 1 1
1 15 8 1998 400
250-260 55-56 40-42 1 1 2003 1 29
2 2 80 18.5 7 2002
1 20 Bayer 2000 16.48 200 22 1999 15 PfizerSquibbBayerGlaxo 60 80 90 20 90 1 2002 11 6
22 50 30 1 2 3 4 5 2001 5000 1000 HMGCoA
statins 10 80 2002 Lipitor 86 Zocor 62 1 7 4 21 12 1 2003 4 1
1 2003 3.6% 20042005 4.1% 2004 4.2 WTO 2003 GDP 9.1 2004 8 GDP GDP 2 3 4 90 5 6 7 12 20021-9 19.6 1
2 3 810 3 4 4 5 6
GMP GSP GMP GMP GMP ISO14001 2002 87 2000 2003 2000 2001
20 2002 83 12 2002 5 1 21.000 44.36% 2 10.280 21.71% 3 8.639 18.25% 4 3.050 6.44% 5 1.910 4.03% 44.879 94.79% 2002 5
1 588.000 57.70% 2 177.690 17.44% 3 146.080 14.34% 4 70.220 6.89% 5 18.440 1.81% 1000.43 98.18% 2003 FDA 2002 2003 130 API0134
ERP OA 2002 ISO14001 GMP 2002 87 GMP 2005 12 31
1 1
1
1
2003 2002 2001 900 561 588 596 80 79 21 12 80 73 19-60 23 22 17. / 36000 20001.50 30274.07 26092.75 10000 10062.81 6397.51 3087.97 2000 1446.17 720.45 406.21 1500 1484.83 1126.18 711.51
( ) DMF ( ) ( ) DMF DMF( ) ( ) 20% 36% ( ) ( )
DMF DMF N- DMF K 2 CO 3 DMSO 2- DMSO NaOH
2003 12 31 1000L 29 1500L 20 2000L 34 2500L 6 3000L 56 4000L 7 5000L 25 6300L 17 156 162 52 32 1 2 1 5 / ()
86.00 2.00 7.40 4.60 79.00 3.00 14.00 4.00 2-89.50 2.00 4.50 4.00 78.00 2.00 15.00 5.00. 75.92 3.51 17.69 2.88 86.89 1.91 9.63 1.57 80.10 3.70 12.84 3.36 85.85 2.63 9.13 2.39 81.67 3.41 11.83 3.09 82.96 3.17 10.99 2.88 2003 ( ) (%) /
= / - 2003 58.70 1.90 () 1 167,715,667.09 55.63 2 25,921,134.21 8.60 3 19,560,852.09 6.49 4 17,063,710.78 5.66 5 13,842,373.86 4.59 244,103,738.03 80.96 3 /
2003 12 31 29,532,746.34 6,272,049.85 23,260,696.49 860,000.00 78.76% 36,127,833.03 7,976,834.51 28,150,998.52 464,803.58 77.92% 1,916,106.00 182,311.57 1,733,794.43 90.49% 2,066,056.49 583,237.99 1,482,818.50 71.77% 3,927,943.85 1,154,228.04 2,773,715.81 70.61% 73,570,685.71 16,168,661.96 57,402,023.75 1,324,803.58 78.02% 6 25561.8 6 ( )
1 2002 0756 2,233.12 1,489,790.00 929,733.57 2 3 4 2002 0760 2002 0761 2002 3354 7,980.77 7,694,922.94 4,229,625.75 3,541.11 1,799,520.00 1,372,461.91 7,567.39 2,267,773.11 2,152,041.11 5 2002 3746 1,264.10 648,767.87 439,531.26 207 6 2002 3747 155,350.00 2,975.31 1,064,407.85 207 25,561.80 15,454,123.92 10,187,801.45 2003 12 31 6 2003 12 31 6 168,520.51 21,754,701.51 2003 5071 5 (m ) 1 2002 0463 207 1,465.00 2 2002 0464 36,994.17 3 2002 2389 19,333.00 4 2002 2622 62,190.94 5 2002 2418 31,204.00 6 2003 5071 17,333.40 7 168,520.51
1 2 3 1
G M P 1 2 3 4 5 6 7 GMP SOP GMPSOP (%) 16,409,734.19 7.97 12,357,880.34 6.00 11,753,588.74 5.71 11,639,012.39 5.65 8,827,062.82 4.29
60,987,278.48 29.62 (%) 2001 60,604,872.77 26.38 2002 79,796,981.86 39.84 2003 60,987,278.48 29.62 (%) 25,773,695.13 8.55 15,719,806.64 5.21 12,776,154.70 4.24 7,518,111.11 2.49 6,481,452.99 2.15 68,269,220.57 22.64 % 2001 41,115,188.05 18.11 2002 43,439,632.47 16.09 2003 68,269,220.57 22.64 1,200 2000 12 2002 ISO 14001
A/OUASB (1) (2) A/O-UASB A- O- UASB- (3) (4) (5) 25
20027 ISO14001 20023 ISO14001 20028 ISO14001 ISO14001
( )
99.5
2 ZC3266389SL 2002.8.30 3266389 3 ZC3351937SL 2002.11.14 3351937 4 ZC3351938SL 2002.11.14 3351938 5 ZC3351939SL 2002.11.14 3351939 6 ZC3351940SL 2002.11.14 3351940 7 ZC3523381SL 2003.5.16 3523381 8 ZC3856059SL 2004.2.23 3856059 JX 9 ZC3856061SL 2004.2.23 3856061 5
10 ZC3856060SL 2004.2.23 3856060 5 11 ZC3962176SL 2004.4.23 3962176 30 12 ZC3962173SL 2004.4.23 3962173 30 13 ZC3926281SL 2004.4.26 3926281 14 ZC3926282SL 2004.4.26 3926282 15 ZC3962175SL 2004.4.23 3962175 JINGXIN 265208 ZL 01 3 40649.3 20021120 20018 23 5 01132018.4 2001.10.26 02110987.7 2002.3.8 02137122.9 2002.9.25 02136740.X 2002.8.30 02111279.9 2002.4.5 1 1 X19990037 H19990059 2001.6.17 2 X19990038 H19990060 2000.6.17 3 X19990039 2001.6.17 4 X20010557 2006.5.26 5 1998X-338 H19980028 H20000445 H20000446 2002.7.1 6 98 H10980041 2002.8.21 X-154
7 1999X-137 H19991033 2001.12.20 8 1999X-138 H19991032 2001.12.20 H20000008 H20000008 9 X20000008 2006.1.12 10 X20010123 H20020344 2007.3.8 11 X20010128 H20020345 2007.3.8 12 X20010118 H20020346 2007.3.8 13 H20030166 H20030212 2008.3.25 14 H20030167 H20030213 2008.3.25 15 H20030168 2008.3.25 16 H20030709 H20030866 2008.8.26 17 H20030710 H20030867 2008.8.26 H20030868 18 H20040004 H20040007 2009.1.7 19 H20040005 H20040008 2009.1.7 45 19 4 2 1000
2002 20031226 200374 320 10 2000 2001 2001 2002
2001 2000 1 2 3 4 5 6 7 8 9 10 11 API0134 12
% 2003 3.57 2002 3.56 2001 3.78
CI
1199911 220001 1999 320003 420004 520007 62001 7200112 82001 920021 1020028 1120028 1220029 1320031 1420031 1520031 2002 162003 AA 17 20034
1920031226 200374 320
90%
2003
1 11 360
1 2 360 1 2 3
ISO 14000 GMP
( ) 2003
2001 12 31 2002 12 31 2003 12 31 2001 2002 2003 2003
2003 2002 2001 16641.16 55.19% 14435.25 53.47% 13710.95 60.39% 8390.28 27.83% 9791.73 36.27% 7924.13 34.90% 3005.05 9.97% 1649.67 6.11% 1013.16 4.46% 2114.07 7.01% 1118.77 4.14% 57.01 0.25% 13509.40 44.81% 12560.17 46.53% 8994.30 39.61% 30150.56 100.00% 26995.42 100.00% 22705.25 100.00%
[2004]4 1 2003 2002 2001
20012002 2003 3,750.0067,750.0015,000.00
2003 12 31
2003 12 31 2003 12 31 17,036.38 2003 12 31 6,000.00 3,000.00 2,500.00 500.00 2003 12 31 10,000,000.00 10,000,000.00 2003 12 31 1,752.00 4,147.75 3,412.21 82.27% 3, 5% 5% 260.43 5% 5% 77.85 310.66 : 2003 2002
32.03 12 2003 12 31 17.37 2003 12 31 1,077.00 795.82 73.89 : 2003 12 31 10.20 2003 12 31 3,005.54 2,001.85 1,003.69 2003 12 31 103.22 1998
3,884,006.79 541,647.21 1,652,315.87 : 2,589,337.86 361,098.14 1,101,543.91 1,294,668.93 180,549.07 550,771.96 3,810,678.18 2,540,452.12 1,270,226.06 7,694,684.97 5,129,789.98 2,564,894.99
1 2,977,524.03 0 1 2,441,524.03 65% 55.00 55.35 0.35 1995 2 500000 25% 124.64 2 15,170,239.25 12,358,693.90 2,811,545.35 3 3,071,683.69 5,682.45 3,066,001.24 2,288,496.78 4 20,780,591.07 21,543,160.07 762,569 23,069,087.85 1,525,927.78 12003
22002 32001,
1999 2 1997 12 31 28.85 1998 1 1 1999 1 31 28.85 2003 4 10, 2003 2002 2001
146,272,430.04
= / = / = / = / = / = / = / = / = /
= / 9 2003 12 31 2002 2001 1 = 2 = 3 (ROE) ROE = P(E0NP2EiMiM0EjMjM0) P NP E0 Ei Ej M0 Mi Mj 4 EPS
EPS = P(S0S1SiMiM0SjMjM0) P S0 S1 Si Sj M0 Mi Mj
2003 0.507 28.725
2003 2002 2001 10.90 6.99 7.81 40.70 36.13 29.39 5.17 14.74 8.46 54.53 53.83 56.61 34.64 33.41 27.19 89.46 89.85 86.38 30.51 30.70 25.01 46.27 40.58 33.84 26.75 22.62 18.12
2003 4.13% 2003 2002 3.91% 2.09% 2003 2002 5.69% 2.65% 2002 4.50% 2.33% 2.17%
3 ERP 1) 2)
5
FDA 3
1,760 10.05 17,688 1,171 16,517
1 500 4490.00 1928.00 5.94 23.82% 2 400 4918.00 1771.30 7.10 17.90% 3 FDA 2856.00 699.00 5.33 22.13% 4 12 () 4192.00 2785.20 5.10 31.6% 5 16456.00 500 4490.00 2990.00 1500.00 400 4918.00 2818.00 2100.00 FDA 2856.00 1986.00 870.00 12 () 4192.00 2392.00 1800.00 16456.00 10186.00 6270.00
500
416
2 400
3 FDA
FDA GMP CGMP
FDA FDA CGMP QC QA CGMP DMF FDA FDA CGMP GMP CGMP FDA
2856 1986.46 400 869 2856 1 10 4 12
1 DCF 2 EBITDA 3 10.05 / 2003 0.507 19.82
1 2 10 3 5 4 5 50 25
0575-6176531
0575-6096898
9
1
5
2004 5 21